학술논문
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Document Type
Article
Author
Madorsky Rowdo, Florencia P.; Xiao, Gu; Khramtsova, Galina F.; Nguyen, John; Martini, Rachel; Stonaker, Brian; Boateng, Richard; Oppong, Joseph K.; Adjei, Ernest K.; Awuah, Baffour; Kyei, Ishmael; Aitpillah, Frances S.; Adinku, Michael O.; Ankomah, Kwasi; Osei-Bonsu, Ernest B.; Gyan, Kofi K.; Altorki, Nasser K.; Cheng, Esther; Ginter, Paula S.; Hoda, Syed; Newman, Lisa; Elemento, Olivier; Olopade, Olufunmilayo I.; Davis, Melissa B.; Martin, M. Laura; Bargonetti, Jill
Source
In Cancer Letters 1 March 2024 584
Subject
Language
ISSN
0304-3835